<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003256'>Coagulopathy</z:hpo> leading to arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> is sometimes seen in patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>It is caused by <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> reacting with negatively charged <z:chebi fb="0" ids="16247">phospholipid</z:chebi> constituents of membranes and coagulation factors </plain></SENT>
<SENT sid="2" pm="."><plain>The patients may also suffer from recurrent fetal loss and neurological manifestations, and may have <z:hpo ids='HP_0004854'>intermittent thrombocytopenia</z:hpo> and low serum concentration of complement factor C4 </plain></SENT>
<SENT sid="3" pm="."><plain>Patients without evidence of SLE or other immunological disorders may also exhibit this <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo>-associated thrombotic tendency </plain></SENT>
<SENT sid="4" pm="."><plain>The patients are often young women, and it is important to be aware of this kind of <z:hpo ids='HP_0003256'>coagulopathy</z:hpo>, because it may take a most severe course in some of the persons affected </plain></SENT>
</text></document>